论文部分内容阅读
本文报告97例男性肝病患者甲状腺激素测定结果,并探讨其对肝脏病变程度及预后的估计价值。资料和方法一、病例来源:收集1988年6月～1991年3月无甲状腺功能异常的男性住院病人97例,年龄20～75岁。同时设健康对照组20例。肝病按1990年(上海)全国肝炎会议修订的标准。肝癌按全国第一届肝癌会议的诊断标准。按肝病性质分5组:1.急性肝炎组18例;2.慢性肝炎组26例(慢性活动性肝炎11例,慢性迁延性肝炎15例);3.肝硬化代偿组15例(酒精性肝硬化7例,肝炎后肝硬化8例);4.肝硬化失代偿组23例(酒精性肝硬化6例,肝炎后肝硬化17例);5.肝癌组15例。
This article reports 97 cases of thyroid hormone in male patients with liver disease, and to explore its degree of liver disease and prognosis of the estimated value. Materials and methods First, the source of the cases: collected from June 1988 to March 1991, 97 cases of male inpatients without thyroid dysfunction, aged 20 to 75 years old. At the same time set 20 cases of healthy control group. Liver disease according to the 1990 (Shanghai) National Hepatitis Conference revised standards. Liver cancer by the first national liver cancer conference diagnostic criteria. According to the nature of liver disease divided into 5 groups: 1. 18 cases of acute hepatitis group; 2. chronic hepatitis group of 26 cases (chronic active hepatitis in 11 cases, chronic persistent hepatitis in 15 cases); 3. Cirrhosis compensatory group of 15 cases (alcoholic Liver cirrhosis in 7 cases, liver cirrhosis in 8 cases); 4 liver cirrhosis decompensation group of 23 patients (alcoholic cirrhosis in 6 cases, hepatitis cirrhosis in 17 cases);